Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Deflazacort
Medication labelDeflazacort oral suspension is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
Why this: Advisory · dailymed-prescription
Deflazacort oral suspension is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
- generic_name
- deflazacort
- product_names
- Deflazacort
- ndc
- 70710-2007, 70710-2007-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en